Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4767946

COc1ccc(C(=O)Nc2ccc3c(c2)CCN(C2CCC2)CC3)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 5/20 0.56
TMPRSS2 O15393 1/20 0.54
TRPV1 Q8NER1 1/20 0.53
SLC2A1 P11166 1/20 0.52
KMT2A Q03164 2/20 0.49
MCHR1 Q99705 2/20 0.49
ALDH1A1 P00352 3/20 0.48
MAPT P10636 3/20 0.48
KDM4E B2RXH2 1/20 0.48
HPGD P15428 1/20 0.48
RAB9A P51151 5/20 0.47
NPC1 O15118 4/20 0.47
POLB P06746 1/20 0.47
OPRM1 P35372 1/20 0.46
NR4A1 P22736 1/20 0.46
MCL1 Q07820 1/20 0.46
NFKB1 P19838 2/20 0.46
NFKB2 Q00653 2/20 0.46
RELA Q04206 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4771074 0.93 HRH3 (0.64) HRH3TMPRSS2TRPV1KMT2AMCHR1
Trifluoroacetic Acid SCHEMBL4767622 0.93 HRH3 (0.51) HRH3TMPRSS2TRPV1SLC2A1RAB9A
Trifluoroacetic Acid SCHEMBL4770822 0.90 RAB9A (0.53) HRH3KMT2AALDH1A1MAPTRAB9A
Trifluoroacetic Acid SCHEMBL4765533 0.90 HRH3 (0.61) HRH3TRPV1SLC2A1RAB9ANPC1
Trifluoroacetic Acid SCHEMBL4774281 0.88 SLC2A1 (0.58) HRH3TRPV1SLC2A1KMT2AALDH1A1
Trifluoroacetic Acid SCHEMBL4772701 0.86 SLC2A1 (0.52) HRH3TRPV1SLC2A1ALDH1A1MAPT
SCHEMBL4768500 0.85 HRH3 (0.57) HRH3TMPRSS2RAB9ANPC1
Trifluoroacetic Acid SCHEMBL4767916 0.85 TMPRSS2 (0.55) HRH3TMPRSS2TRPV1SLC2A1KMT2A
Trifluoroacetic Acid SCHEMBL4765269 0.85 MAPT (0.51) HRH3TRPV1KMT2AMCHR1ALDH1A1
Trifluoroacetic Acid SCHEMBL4766896 0.85 MAPT (0.51) HRH3TRPV1KMT2AMCHR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP claimed
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists GLAXO GROUP LIMITED (GB) 2007-03-15 US claimed
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists HRH3, HRH4, HRH1 HRH3 1/4885TMPRSS2 1089/4885TRPV1 125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.